Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-018194-31Phase 2Unknown
Phase 2, single-arm trial of amlodipine in Raynaud disease, sponsored by Pharmarama. Primary endpoints: Improvement of digital blood flow and symptoms and Practicality of gel application. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-018194-31.